» Authors » Margaret Hood

Margaret Hood

Explore the profile of Margaret Hood including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 769
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Lambiase P, Theuns D, Murgatroyd F, Barr C, Eckardt L, Neuzil P, et al.
Eur Heart J . 2022 Jan; 43(21):2037-2050. PMID: 35090007
Aims: To report 5-year outcomes of EFFORTLESS registry patients with early generation subcutaneous implantable cardioverter-defibrillator (S-ICD) devices. Methods And Results: Kaplan-Meier, trend and multivariable analyses were performed for mortality and...
2.
Boersma L, Barr C, Knops R, Theuns D, Eckardt L, Neuzil P, et al.
J Am Coll Cardiol . 2017 Aug; 70(7):830-841. PMID: 28797351
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to defibrillate ventricular arrhythmias, avoiding drawbacks of transvenous leads. The global EFFORTLESS S-ICD (Evaluation oF FactORs ImpacTing CLinical Outcome and Cost EffectiveneSS...
3.
Lambiase P, Gold M, Hood M, Boersma L, Theuns D, Burke M, et al.
Heart Rhythm . 2016 Jan; 13(5):1066-1074. PMID: 26767422
Background: The subcutaneous implantable cardioverter-defibrillator (S-ICD) is a potential alternative to transvenous systems in hypertrophic cardiomyopathy (HCM) where lead complications are a significant issue. Objectives: To compare the S-ICD efficacy...
4.
Knops R, Brouwer T, Barr C, Theuns D, Boersma L, Weiss R, et al.
Europace . 2015 Sep; 18(7):1010-5. PMID: 26324840
Aims: The subcutaneous implantable cardioverter defibrillator (S-ICD) was introduced to overcome complications related to transvenous leads. Adoption of the S-ICD requires implanters to learn a new implantation technique. The aim...
5.
Simon T, Cawthon M, Stanford S, Popalisky J, Lyons D, Woodcox P, et al.
Pediatrics . 2014 May; 133(6):e1647-54. PMID: 24819580
Objectives: The goal of this study was to develop an algorithm based on International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM), codes for classifying children with chronic disease (CD)...
6.
Lambiase P, Barr C, Theuns D, Knops R, Neuzil P, Johansen J, et al.
Eur Heart J . 2014 Mar; 35(25):1657-65. PMID: 24670710
Aims: The totally subcutaneous implantable-defibrillator (S-ICD) is a new alternative to the conventional transvenous ICD system to minimize intravascular lead complications. There are limited data describing the long-term performance of...
7.
Weiss R, Knight B, Gold M, Leon A, Herre J, Hood M, et al.
Circulation . 2013 Aug; 128(9):944-53. PMID: 23979626
Background: The most frequent complications associated with implantable cardioverter-defibrillators (ICDs) involve the transvenous leads. A subcutaneous implantable cardioverter-defibrillator (S-ICD) has been developed as an alternative system. This study evaluated the...
8.
Earle N, Crawford J, Smith W, Hayes I, Shelling A, Hood M, et al.
Heart Rhythm . 2012 Nov; 10(2):233-8. PMID: 23123674
Background: Long QT syndrome (LQTS) prevalence is estimated at 4 of 10,000 based on community electrocardiogram (ECG) screening, about which there is disagreement regarding efficacy, accuracy, cost-effectiveness, and practicality. Family...
9.
10.
Lee K, Lau C, Tse H, Echt D, Heaven D, Smith W, et al.
J Am Coll Cardiol . 2007 Aug; 50(9):877-83. PMID: 17719475
Objectives: The purpose of this study was to evaluate the feasibility and safety of a novel technology that uses energy transfer from an ultrasound transmitter to achieve cardiac stimulation without...